未登录

R

Renhua Guo

Nanjing Medical University

H指数:29

被引数:4,964

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

High-Quality Photoplethysmography Signal Enabled by Narrowband Red Phosphor Converted Light-Emitting Diodes for Accurate Blood-Pressure Monitoring

由窄带红光荧光粉转换发光二极管实现的高质量光电容积脉搏波信号，用于精确的血压监测

Advanced Materials

IF26.8

2026-08-100

PRE

Boosting Mn4+ Luminescence Through Hybrid Single-Crystal Engineering Suppressing Energy Migration and Defect-Related Quenching

通过抑制能量迁移和缺陷相关猝灭的杂化单晶工程增强Mn4+发光

Advanced Optical Materials

IF7.2

2026-07-300

PRE

Copy Number Amplification and c-Myc Transcriptional Activation-Mediated RNA-Binding Protein MEX3A Promotes EGFR-TKI Resistance in Non-Small-Cell Lung Cancer

拷贝数扩增和c-Myc转录激活介导的RNA结合蛋白MEX3A促进非小细胞肺癌中的EGFR-TKI耐药性

Thoracic Cancer

IF2.3

2026-05-040

OAAI

Achieving 57.15% EQE in Mn4+ Non-equivalent Doped Fluoride Single Crystals via a Rapid Synthesis for Next-Generation Display Lighting

通过快速合成方法在Mn4+非等价掺杂氟化物单晶中实现57.15%的外量子效率，用于下一代显示照明。

Inorg. Chem. Front.

IF0

2025-11-220

PRE

Theoretical Prediction-Assisted Synthesis of Narrow-Band Red-Emitting Fluoride Phosphors with High Film-Forming Ability for Mini Light-Emitting Diode Displays

理论预测辅助的窄带红光发射氟化物荧光粉的高成膜性合成及其在微发光二极管显示中的应用

Laser & Photonics Reviews

IF10

2025-11-050

PRE

Third-Generation EGFR-TKIs Combined With Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Real-World Study

第三代EGFR-TKIs联合化疗在晚期非小细胞肺癌中的应用：一项真实世界研究

IF4.3

2025-11-010

OAAI

Quantitative and Dynamic ctDNA as a Biomarker of Response and Survival in Patients With Advanced Lung Squamous Cell Carcinoma Receiving Immunochemotherapy or Chemotherapy Alone

定量和动态循环肿瘤DNA作为接受免疫化疗或单纯化疗的晚期肺鳞状细胞癌患者中反映疗效和生存的生物标志物

Journal of Thoracic Oncology

IF20.8

2025-06-030

PRE

Circular RNA circHSPA8 Aggravates Metastasis by Acting as a Competitive Inhibitor of miR-195-5p to Upregulate WNT3A Expression in Breast Cancer

环状RNA circHSPA8通过作为miR-195-5p的竞争性抑制剂来上调WNT3A表达，从而加剧乳腺癌的转移

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

IF4.2

2025-03-180

OAAI

NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer

NNMT通过形成EGR1和乳酸介导的双重正反馈回路促进非小细胞肺癌获得性EGFR-TKI耐药性。

MOLECULAR CANCER

IF33.9

2025-03-150

OA

Molecular features of NSCLC patients with liver metastasis

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2024-09-240

OAAI

Concomitant genomic features stratify prognosis to patients with advanced EGFR mutant lung cancer

MOLECULAR CARCINOGENESIS

IF3.2

2024-06-111

PRE

Paclitaxel liposome (Lipusu) based chemotherapy combined with immunotherapy for advanced non-small cell lung cancer: a multicenter, retrospective real-world study

基于紫杉醇脂质体 (Lipusu) 的化疗联合免疫治疗晚期非小细胞肺癌的多中心回顾性真实世界研究

IF3.4

2024-01-1812

OAAI

Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study

LANCET RESPIRATORY MEDICINE

IF32.8

2023-10-0123

PRE

Lu, Shun; Zhou, Jianying; Jian, Hong; Wu, Lin; Cheng, Ying; Fan, Yun; Fang, Jian; Chen, Gongyan; Zhang, Zhihong; Lv, Dongqing; Jiang, Liyan; Wu, Rong; Jin, Xiangming; Zhang, Xiaodong; Zhang, Junhong; Xie, Conghua; Sun, Gengyun; Huang, Dongning; Cui, Jiuwei; Guo, Renhua; Han, Zhigang; Chen, Zhendong; Liang, Jin; Zhuang, Wu; Hu, Xingsheng; Zang, Aimin; Zhang, Yi; Cang, Shundong; Lan, Yuanbo; Chen, Xi; Liu, Laiyu; Li, Xingya; Chen, Jun; Ma, Rui; Guo, Yanzhen; Sun, Ping; Tian, Panwen; Pan, Yueyin; Liu, Zhe; Cao, Peiguo; Ding, Lieming; Wang, Yang; Yuan, Xiaobin; Wu, Pengxiang

B4GALT1 promotes immune escape by regulating the expression of PD-L1 at multiple levels in lung adenocarcinoma

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2023-06-1224

OAAI

LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer

CELL DEATH & DISEASE

IF9.6

2023-05-0856

OAAI

Efficacy and Safety of Anti-Programmed Death-Ligand 1 Monoclonal Antibody Socazolimab With Carboplatin and Etoposide for Extensive-Stage SCLC: Results From the Phase 1b Clinical Trial

JTO CLINICAL AND RESEARCH REPORTS

IF3.5

2023-04-013

OA

Safety, efficacy, and pharmacokinetics of SH-1028 in EGFR T790M-positive advanced non-small cell lung cancer patients: A dose-escalation phase 1 study

IF5.1

2023-02-223

OAAI

MNX1-AS1 Promotes Phase Separation of IGF2BP1 to Drive c-Myc-Mediated Cell-Cycle Progression and Proliferation in Lung Cancer

CANCER RESEARCH

IF16.6

2022-10-1036

OA

Efficacy and safety of camrelizumab plus apatinib in previously treated patients with advanced non-small cell lung cancer harboring EGFR or ALK genetic aberration

TRANSLATIONAL LUNG CANCER RESEARCH

IF3.5

2022-06-0114

OAAI

Copy number amplification and SP1-activated lncRNA MELTF-AS1 regulates tumorigenesis by driving phase separation of YBX1 to activate ANXA8 in non-small cell lung cancer

IF7.3

2022-05-0430

PRE